We are delighted by today's decision to allow patients with advanced prostate cancer to receive abiraterone on the NHS.
This drug was discovered at the Institute of Cancer Research and is the result of more than two decades of dedicated work by our scientists and and collaborators.
In clinical trials of men with advanced prostate cancer who have already tried chemotherapy, it has been shown to extend life by an average of four months and improve quality of life.
More top news
Microsoft's new system Windows 8 has been met with approval after its disastrous predecessor but users have yet to be entirely convinced.
Alton Towers crash victim Leah Washington, who lost a leg as a result of the horrific incident, celebrated her 18th birthday last night.
American Football's first female coach, Jen Welter, is hoping to be an inspiration across the globe after being hired by Arizona Cardinals